Cover Image for Well Capitalised- Consumer Wellness, Preventive Health & Longevity Sector Capital Roundtable
Cover Image for Well Capitalised- Consumer Wellness, Preventive Health & Longevity Sector Capital Roundtable
Avatar for TCR Healthcare & LifeSciences
22 Went

Well Capitalised- Consumer Wellness, Preventive Health & Longevity Sector Capital Roundtable

Google Meet
Registration
Past Event
Please click on the button below to join the waitlist. You will be notified if additional spots become available.
About Event

Well Capitalised A Closed-Door Capital Conversation on India's Consumer Wellness, Preventive Health & Longevity Sector TCR Healthcare · Virtual · April 2026 · By Invitation Only


India's consumer health market is generating its own capital cycle - and it is moving faster than the institutional frameworks built to evaluate it.

Nutraceuticals, preventive diagnostics, mental health platforms, D2C health brands, and longevity- the science of extending healthspan, not just lifespan- are collectively attracting a wave of venture and growth capital that the market has not seen before. The opportunity is real. So is the noise. The difference between a wellness brand and a wellness business - between a longevity thesis and a longevity company- is not always visible from the outside.

Well Capitalised is a closed-door virtual room convened by TCR Healthcare for twelve to fifteen investors, founders, and sector professionals who are actively operating in this market. Not a panel. Not a webinar. A structured 90 minute conversation among people who have skin in the game - capital deployed, companies building, mandates live.

The room will work through three questions that the market has not answered cleanly.

  1. What does an institutionally investable consumer health or longevity company actually look like in 2026 and what is the capital community backing versus what it claims to back?

  2. Where is the line between a brand with strong repeat purchase and a business with defensible unit economics - and how are investors drawing it in due diligence right now?

  3. What specific clinical validation and regulatory positioning do you need to see to underwrite longevity as a healthcare investment thesis rather than a wellness narrative?


Participation is by invitation only. The room is composed- not open. Every participant is there because they are directly relevant to the conversation, and the conversation is directly relevant to what they are working on.

Your Moderators

Manav Narang- Head of India, Plug and Play. Manav leads Plug and Play's India operations, one of the world's largest innovation platforms connecting startups, corporations, and capital across 60+ locations globally. He brings a front-row view of where India's health and consumer innovation is heading and where capital is paying attention.

Anmol Sinha — Investor, HealthQuad. Anmol looks after HealthQuad Investments, one of Asia's most active dedicated & leading healthcare funds. She brings live deal flow intelligence, active investment thesis, and a direct lens on what institutional healthcare capital is actually underwriting in 2026 versus what it claims to back.

The room will be co-moderated by Kinjal Singhal, Managing Partner of TCR Healthcare.

A post-room intelligence brief will be distributed to all participants within 72 hours- covering capital signals, deal flow intelligence, and the analytical insights that emerge from the discussion.


TCR Healthcare is a private capital coordination platform operating across India's healthcare and life sciences sector. Well Capitalised is the first room in TCR's 2026 Healthcare Roundtable Series.

Avatar for TCR Healthcare & LifeSciences
22 Went